Apellis Pharmaceuticals Inc (APLS)

19.47 -0.57 (-2.84%) USD  |  NASDAQ  |  Jul 18, 16:00
19.47 0.00 (0.00%) Pre-Market: 20:00
More

Apellis Pharmaceuticals EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
Ardelyx Inc Upgrade
Arvinas Inc Upgrade
Alnylam Pharmaceuticals Inc Upgrade
Vertex Pharmaceuticals Inc Upgrade
TG Therapeutics Inc Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to Revenues Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade